Cargando…
Gene Mutations in Lung Cancer: Promising Predictive Factors for the Success of Molecular Therapy
Gefitinib and erlotinib are two new treatments for advanced lung cancer. Gene mutations in the cancer may help predict which patients will respond to these treatments
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545205/ https://www.ncbi.nlm.nih.gov/pubmed/15696203 http://dx.doi.org/10.1371/journal.pmed.0020013 |